bpc-157 regulatory status BPC 157 UK: Identity, Evidence & UK Peptides – It's Me & You Repost @peptides with @use.repost ・・・

Rafii MS, Tuszynski MH, Thomas RG, Barba D, Brewer JB, et al

The peptide helps calm inflammation while simultaneously supporting barrier function, addressing both sides of the eczema equation

Potential side effects may include injection-site redness, swelling, bruising, itching, tenderness, small lumps, headache, fatigue, nausea, appetite changes, abdominal discomfort, stool changes, dizziness, altered sleep, mood changes, or feeling off. Allergic or immune reactions are also possible, and the FDA has specifically raised concerns about immunogenicity and peptide-related impurities in compounded BPC-157

Material not manufactured and tested to injectable-drug standards may carry concerns around microbial contamination, endotoxin, particulates, and purity that approved parenteral drugs are specifically controlled against, lot by lot